Schedule 13G ownership disclosure

Flexion Therapeutics Inc

Security class unavailable · CUSIP: 33938J106

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,379,464
Percent of class
14.0700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-17-008211
Form type
SC 13G/A
Filer
Flexion Therapeutics Inc
CIK
CIK 1419600
Filed
Feb 14, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub